Clincosm LogoSign in Get a demo

relapsing forms of multiple sclerosis

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsing Forms of Multiple Sclerosis Trial (BIIB091, DRF, Placebo)

Not yet recruiting
  • Relapsing Forms of Multiple Sclerosis
  • (no location specified)
Mar 23, 2023

Ocrelizumab and Ofatumumab Administration in Relapsing Multiple

Completed
  • Relapsing Forms of Multiple Sclerosis
  • Lutherville, Maryland
  • +1 more
Oct 19, 2022

Relapsing Forms of Multiple Sclerosis Trial in China, Japan (Diroximel fumarate)

Recruiting
  • Relapsing Forms of Multiple Sclerosis
  • Diroximel fumarate
  • Tianjin, China
  • +23 more
Jul 22, 2022

Relapsing Forms of Multiple Sclerosis Trial in Australia, United States (EHP-101 25 mg OD, EHP-101 25 mg BID, EHP-101 50 mg OD)

Recruiting
  • Relapsing Forms of Multiple Sclerosis
  • EHP-101 25 mg OD
  • +3 more
  • Cullman, Alabama
  • +3 more
Apr 29, 2022

Plegridy Observational Program

Completed
  • Relapsing Forms of Multiple Sclerosis
  • peginterferon beta-1a
  • Homewood, Alabama
  • +151 more
Feb 10, 2022

Relapsing Forms of Multiple Sclerosis Trial in Worldwide (Fingolimod)

Completed
Has Results
  • Relapsing Forms of Multiple Sclerosis
  • Cullman, Alabama
  • +457 more
Mar 26, 2021

Relapsing Forms of Multiple Sclerosis Trial in United States (dimethyl fumarate, tetanus diphtheria toxoids vaccine, 23-valent

Completed
Has Results
  • Relapsing Forms of Multiple Sclerosis
  • dimethyl fumarate
  • +4 more
  • Gilbert, Arizona
  • +13 more
May 1, 2017

Relapsing Forms of Multiple Sclerosis Trial in United States (BG00012 (DMF))

Completed
Has Results
  • Relapsing Forms of Multiple Sclerosis
  • BG00012 (DMF)
  • Cullman, Alabama
  • +36 more
Feb 14, 2017

DMF and Its Impact on PROs in Suboptimal GA Responders With RMS

Completed
  • Relapsing Forms of Multiple Sclerosis
  • dimethyl fumarate
  • Birmingham, Alabama
  • +61 more
Jul 22, 2016

Relapsing-Remitting Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis Trial (dimethyl fumarate, Placebo)

Withdrawn
  • Relapsing-Remitting Multiple Sclerosis
  • Relapsing Forms of Multiple Sclerosis
  • dimethyl fumarate
  • Placebo
  • (no location specified)
Apr 11, 2016

Relapsing Forms of Multiple Sclerosis Trial in Canada, Puerto Rico, United States (Fingolimod, Standard MS DMTs)

Completed
Has Results
  • Relapsing Forms of Multiple Sclerosis
  • Birmingham, Alabama
  • +148 more
Jan 14, 2014

Relapsing Forms of Multiple Sclerosis Trial in Cleveland, Milwaukee (Plasma exchange, natalizumab treatment)

Completed
  • Relapsing Forms of Multiple Sclerosis
  • Plasma exchange
  • natalizumab treatment
  • Cleveland, Ohio
  • +1 more
Sep 3, 2009